(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).
Apr 23, 2018
0
4
(HealthDay)—Noninvasive cardiac testing leads to longer length of stay (LOS) for patients presenting to the emergency department with chest pain, according to a study published online Nov. 14 in JAMA Internal Medicine to ...
Nov 15, 2017
0
0
Patients who go to the emergency room (ER) with chest pain often receive unnecessary tests to evaluate whether they are having a heart attack, a practice that provides no clinical benefit and adds hundreds of dollars in health-care ...
Nov 14, 2017
0
2
(HealthDay)—Assessment of hand function is an important component in the clinical evaluation of patients with rheumatoid arthritis (RA) and systemic sclerosis (SSc), according to a study published online March 21 in the ...
Mar 30, 2017
0
0
(HealthDay)—Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response ...
Jun 1, 2016
0
4
Diagnosing patients with medical labels to describe mental health conditions or severe mental health illnesses such as 'personality disorder' or 'schizophrenia', can have negative impacts on professionals working with them ...
Aug 18, 2015
1
254
(HealthDay)—Two new drugs for adults with irritable bowel syndrome with diarrhea (IBS-D) were approved by the U.S. Food and Drug Administration on Wednesday.
May 28, 2015
0
9
(HealthDay)—A new drug to treat adults with ulcerative colitis and Crohn's disease has been approved by the U.S. Food and Drug Administration.
May 21, 2014
0
0
Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...
Apr 2, 2014
0
0
In ICU patients who have septic shock, the anatomic source of infection has a strong effect on the chances of survival, according to a new study from researchers in Canada.
May 20, 2013
0
0
